Amber Balazs
Impact in
-
- Computational Drug Discovery Methods
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Chemical Synthesis and Analysis
- Protein Structure and Dynamics
- Receptor Mechanisms and Signaling
Papers in
-
- Protein Degradation and Inhibitors 1
- Protein Structure and Dynamics 1
- Oncology 2
- Peptidase Inhibition and Analysis 1
- PARP inhibition in cancer therapy 1
- Co-authors
- Elisabetta Chiarparin (3 shared papers)James S. Scott (1 shared paper)C. R. Diène (1 shared paper)Andy Pike (2 shared papers)David M. Wilson (1 shared paper)Ina Terstiege (1 shared paper)Thomas G. Hayhow (1 shared paper)Nichola L. Davies (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)Cancer Research (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Amber Balazs
4 papers receiving 61 citations
Peers
Comparison fields: 5 of 24
- Computational Theory and Mathematics 12
- Molecular Biology 48
- Oncology 18
- Pharmaceutical Science 3
- Hematology 5
Countries citing papers authored by Amber Balazs
This map shows the geographic impact of Amber Balazs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Balazs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Balazs more than expected).
Fields of papers citing papers by Amber Balazs
This network shows the impact of papers produced by Amber Balazs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Balazs. The network helps show where Amber Balazs may publish in the future.
Co-authors
The 25 scholars most cited alongside Amber Balazs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 32 | |
| 2 | 2019 | 23 | |
| 3 | 2021 | 4 | |
| 4 | 2022 | 3 |
About Amber Balazs
Amber Balazs is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Computational Theory and Mathematics and Radiology, Nuclear Medicine and Imaging, having authored 4 papers that have together received 62 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (1 paper), Protein Degradation and Inhibitors (1 paper), Molecular spectroscopy and chirality (1 paper), Advanced NMR Techniques and Applications (1 paper), PARP inhibition in cancer therapy (1 paper), Computational Drug Discovery Methods (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Protein Structure and Dynamics (1 paper). The work is most often cited by research in Computational Theory and Mathematics (12 citations), Molecular Biology (48 citations), Oncology (18 citations), Pharmaceutical Science (3 citations) and Hematology (5 citations). Amber Balazs has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Elisabetta Chiarparin, James S. Scott, C. R. Diène, Andy Pike, David M. Wilson, Ina Terstiege, Thomas G. Hayhow, Nichola L. Davies, Charlene Fallan and Johan R. Johansson. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.